Vasiliki Irene Aivaliotis1, Yvonne Lee2, Jasmine Zia3, Wahid Wassef4, Mark Abramson5, Walter Park6,2. 1. Department of Medicine, Stanford Hospital, Stanford, CA, USA. vickiea@stanford.edu. 2. Division of Gastroenterology, Stanford Hospital, Stanford, CA, USA. 3. Division of Gastroenterology, University of Washington Medical Center, Seattle, WA, USA. 4. Division of Gastroenterology, University of Massachusetts, Worcester, MA, USA. 5. Center for Integrative Medicine, Stanford School of Medicine, Stanford, CA, USA. 6. Department of Medicine, Stanford Hospital, Stanford, CA, USA.
Abstract
BACKGROUND: Patients with chronic pancreatitis (CP) have substantially impaired quality of life (QOL) both physically and mentally. Mindfulness therapy is a form of treatment that has been shown to be beneficial in many medical conditions but has not been evaluated in the CP patient population. AIMS: The aims of this study were (1) to test the feasibility and usability of a novel telephone-based mindfulness therapy service for patients with CP and (2) to determine whether there was any effect on CP quality of life. METHODS: We recruited ten patients with suspected or confirmed CP and five controls who were asked to utilize our telephone-based mindfulness therapy service daily for 28 days. Feasibility of the service was defined as the fraction of subjects with a ≥50% compliance rate. Usability was assessed using a System Usability Scale (SUS). QOL was evaluated using the SF-36 questionnaire and the Pancreatitis Quality of Life Instrument (PANQOLI). Paired t tests were used to compare the SF-36 and PANQOLI pre- and post-intervention. RESULTS: There was an overall compliance rate of 67%. The mean SUS score for all participants was 79.3, above the average published score of 68. Results showed a significant improvement in the SF-36 Mental Component Summary scores after 28 days of mindfulness therapy for patients with CP, t(9) = 2.48, p = 0.035. There was also a significant improvement in the mean total PANQOLI scores in CP patients, t(9) = 2.41, p = 0.04, most notably in the social domain. CONCLUSION: Our telephone-based mindfulness therapy service represents a feasible and easily usable treatment adjunct for patients with CP, which may provide benefit in QOL by improving mental health-related domains.
BACKGROUND:Patients with chronic pancreatitis (CP) have substantially impaired quality of life (QOL) both physically and mentally. Mindfulness therapy is a form of treatment that has been shown to be beneficial in many medical conditions but has not been evaluated in the CP patient population. AIMS: The aims of this study were (1) to test the feasibility and usability of a novel telephone-based mindfulness therapy service for patients with CP and (2) to determine whether there was any effect on CP quality of life. METHODS: We recruited ten patients with suspected or confirmed CP and five controls who were asked to utilize our telephone-based mindfulness therapy service daily for 28 days. Feasibility of the service was defined as the fraction of subjects with a ≥50% compliance rate. Usability was assessed using a System Usability Scale (SUS). QOL was evaluated using the SF-36 questionnaire and the Pancreatitis Quality of Life Instrument (PANQOLI). Paired t tests were used to compare the SF-36 and PANQOLI pre- and post-intervention. RESULTS: There was an overall compliance rate of 67%. The mean SUS score for all participants was 79.3, above the average published score of 68. Results showed a significant improvement in the SF-36 Mental Component Summary scores after 28 days of mindfulness therapy for patients with CP, t(9) = 2.48, p = 0.035. There was also a significant improvement in the mean total PANQOLI scores in CP patients, t(9) = 2.41, p = 0.04, most notably in the social domain. CONCLUSION: Our telephone-based mindfulness therapy service represents a feasible and easily usable treatment adjunct for patients with CP, which may provide benefit in QOL by improving mental health-related domains.
Entities:
Keywords:
Chronic pancreatitis; Mindfulness therapy; Mobile application; Quality of life
Authors: Haulie Dowd; Michael J Hogan; Brian E McGuire; Mary C Davis; Kiran M Sarma; Rosemary A Fish; Alex J Zautra Journal: Clin J Pain Date: 2015-06 Impact factor: 3.442
Authors: Madhav Goyal; Sonal Singh; Erica M S Sibinga; Neda F Gould; Anastasia Rowland-Seymour; Ritu Sharma; Zackary Berger; Dana Sleicher; David D Maron; Hasan M Shihab; Padmini D Ranasinghe; Shauna Linn; Shonali Saha; Eric B Bass; Jennifer A Haythornthwaite Journal: JAMA Intern Med Date: 2014-03 Impact factor: 21.873
Authors: Susan A Gaylord; Olafur S Palsson; Eric L Garland; Keturah R Faurot; Rebecca S Coble; J Douglas Mann; William Frey; Karyn Leniek; William E Whitehead Journal: Am J Gastroenterol Date: 2011-06-21 Impact factor: 10.864
Authors: Markus Wehler; Ralf Nichterlein; Bernhard Fischer; Michael Farnbacher; Udo Reulbach; Eckhart Georg Hahn; Thomas Schneider Journal: Am J Gastroenterol Date: 2004-01 Impact factor: 10.864
Authors: Jasmine K Zia; Thai Le; Sean Munson; Margaret M Heitkemper; George Demiris Journal: Clin Transl Gastroenterol Date: 2015-07-02 Impact factor: 4.488
Authors: Dhiraj Yadav; Tonya M Palermo; Anna E Phillips; Melena D Bellin; Darwin L Conwell Journal: Curr Opin Gastroenterol Date: 2021-09-01 Impact factor: 2.741
Authors: Tonya M Palermo; Emily F Law; Mark D Topazian; Katherine Slack; Blake F Dear; Yeon Joo Ko; Santhi Swaroop Vege; Evan Fogel; Guru Trikudanathan; Dana K Andersen; Darwin L Conwell; Dhiraj Yadav Journal: Clin Transl Gastroenterol Date: 2021-06-18 Impact factor: 4.488